Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited)

v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020   40,618,766    
Beginning balance at Dec. 31, 2020 $ 123,149 $ 406 $ 326,390 $ (203,647)
Increase (Decrease) in Stockholders' Equity        
Net loss (6,660)     (6,660)
Stock-based compensation 2,694   2,694  
Issuance of restricted and performance stock units (in shares)   94,533    
Issuance of restricted and performance stock units 0 $ 1 (1)  
Exercise of stock options and employee stock purchase plan (in shares)   129,418    
Exercise of stock options and employee stock purchase plan 521 $ 1 520  
Ending balance (in shares) at Mar. 31, 2021   40,842,717    
Ending balance at Mar. 31, 2021 $ 119,704 $ 408 329,603 (210,307)
Beginning balance (in shares) at Dec. 31, 2021 41,736,950 41,736,950    
Beginning balance at Dec. 31, 2021 $ 112,550 $ 417 342,765 (230,632)
Increase (Decrease) in Stockholders' Equity        
Net loss (11,475)     (11,475)
Stock-based compensation 2,678   2,678  
Issuance of restricted and performance stock units (in shares)   215,287    
Issuance of restricted and performance stock units 0 $ 2 (2)  
Exercise of stock options and employee stock purchase plan (in shares)   20,750    
Exercise of stock options and employee stock purchase plan $ 98 $ 1 97  
Ending balance (in shares) at Mar. 31, 2022 41,972,987 41,972,987    
Ending balance at Mar. 31, 2022 $ 103,851 $ 420 $ 345,538 $ (242,107)